Zen Technologies Limited

₹754 crore

reflecting strong operational discipline and cost efficiency. Our consolidated order book stands at ₹754 crores and maintain a debt free balance sheet. Our Consolidated performance was further supported by str

100%

ubsidiaries — Applied Research International Private Limited (ARIPL), in which we are consolidating 100% of the financials, and Unistring Tech Solutions Private Limited (UTS), with 51% consolidation. Our

51%

are consolidating 100% of the financials, and Unistring Tech Solutions Private Limited (UTS), with 51% consolidation. Our financial position remains robust, with liquidity of ₹918 crores as of June 30,

₹918 crore

te Limited (UTS), with 51% consolidation. Our financial position remains robust, with liquidity of ₹918 crores as of June 30, 2025, providing significant flexibility to pursue emerging growth opportunities. D

76%

advanced strategic priorities through the successful acquisition of TISA Aerospace Private Limited (76% shareholding). This acquisition marks expansion into the high-growth UAV and loitering munitions s

₹800 crore

across our in Looking ahead to H1FY26, we remain confident achieving our order inflow guidance of ₹800 crores. Out of which we have secured orders amounting to ₹150 crores till date, with the remaining ₹650 c

₹150 crore

chieving our order inflow guidance of ₹800 crores. Out of which we have secured orders amounting to ₹150 crores till date, with the remaining ₹650 crores expected to materialize within the first half. In additi

₹650 crore

crores. Out of which we have secured orders amounting to ₹150 crores till date, with the remaining ₹650 crores expected to materialize within the first half. In addition, we expect orders to be placed under th

₹6,000 crore

ecuting our long- term strategy and are confident in maintaining our targeted cumulative revenue of ₹6,000 crores over the next 3 financial years. 2 Strengthening Strategic Capabilities through Targeted Ac

rs. 2

fident in maintaining our targeted cumulative revenue of ₹6,000 crores over the next 3 financial years. 2 Strengthening Strategic Capabilities through Targeted Acquisitions Zen Technologies has compl

₹ 148.58

otal: 64.26 Cr Total: 158.22 Cr Total: 754.56 Cr *Note: Order book as at 30th June 2025 includes ₹ 148.58 Cr relating to subsidiaries companies. ©Zen Technologies Limited – All Rights Reserved. 6 Diversi

52.17%

Tax Q1FY26 (Unaudited) Q4FY25 (Audited) Q1FY25 (Unaudited) 111.06 19.89 130.95 73.01 57.94 52.17% 38.05 34.26% 1.38 3.07 53.48 37.12 293.50 24.36 317.85 199.12 118.74 40.46% 94.38 32.

“recently across our in Looking ahead to H1FY26, we remain confident achieving our order inflow guidance of ₹800 crores.”

“In addition, we expect orders to be placed under the government’s emergency procurement plan, particularly for anti-drone systems.”

“While FY26 is likely to be a year of consolidation, we remain focused on executing our long- term strategy and are confident in maintaining our targeted cumulative revenue of ₹6,000 crores over the next 3 financial years.”

Total

4

Sub

1

Disclaimer

1

Sub

Investor Presentation Please find attached Investor Presentation on the Un-audited Financial Results of the Company for the quarter ended June 30, 2025. above The https://www.zentechnologies.com/calls-and-conferences information available also is on the website of the Company: This is for your kind information and records. Thanking you Yours faithfully, For Zen Technologies Limited Sourav Dhar Company Secretary & Compliance Officer Encl: As above Investor Presentation Q 1 F Y 2 6 NSE: ZENTEC B SE: ZENTEC - 533339 BLOOMBERG: ZEN IN REUTERS: ZETE. BO Management Commentary Mr Ashok Atluri CHAIRMAN & MANAGING DIRECTOR “Our Q1FY26 results reflect moderation in topline growth, we believe this is a temporary adjustment phase long term growth trajectory. with a much stronger temporary moderation, our business Despite this fundamentals remain strong. We have successfully maintained our EBITDA and PAT margins, reflecting strong operational discipline and cost efficiency. Our consolidated order b

Total

754.56 Cr *Note: Order book as at 30th June 2025 includes ₹ 148.58 Cr relating to subsidiaries companies. ©Zen Technologies Limited – All Rights Reserved. 6 Diversified Consolidated Order Book + = Total 754.56 Domestic 637.15 Export 117.41 *Note: Order book as at 30th June 2025 includes ₹ 148.58 Cr relating to subsidiaries companies. 7 Financial Statement Summary Summary of Standalone Profit & Loss Statement Particulars (₹ in Crore) KEY PERFORMANCE INDICATORS Sales Other Operating Revenue Total Revenue Total Operating Expenses EBITDA EBITDA Margins Operational EBITDA Operational EBITDA Margins Interest Cost Depreciation Profit Before Tax Profit After Tax Q1FY26 (Unaudited) Q4FY25 (Audited) Q1FY25 (Unaudited) 111.06 19.89 130.95 73.01 57.94 52.17% 38.05 34.26% 1.38 3.07 53.48 37.12 293.50 24.36 317.85 199.12 118.74 40.46% 94.38 32.16% 3.61 2.94 112.19 84.92 253.96 3.05 257.00 150.76 106.24 41.83% 103.20 40.64% 1.02 2.24 102.98 74.18 ©Zen Technologies Limited – All Rights Reserved. 8 Fin

Disclaimer

Statements Certain in this presentation concerning our future growth prospects are forward-looking statements, which involve a number of risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The relating to these risks and uncertainties limited to, statements include, but are not risks and uncertainties regarding fluctuations in earnings, intense competition, political instability and general economic conditions affecting our industry. The company does not undertake to update any forward-looking statement that may be made from time to time by or on behalf of the Company. ©2018 ZEN TECHNOLOGIES LIMITED., ALL RIGHTS RESERVED. ZEN TECHNOLOGIES LOGO IS A TRADEMARK OF ZEN TECHNOLOGIES LIMITED. IN ADDITION TO COMPANY DATA, DATA FROM MARKET RESEARCH AGENCIES, STOCK EXCHANGES AND INDUSTRY PUBLICATIONS HAS BEEN USED FOR THIS PRESENTATION. THIS MATERIAL WAS USED DURING AN ORAL PRESENTATION; IT IS NOT A COMPLETE RECORD OF THE D